Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “TOCILIZUMAB”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01693653
What this trial is testing

Tocilizumab for the Treatment of Behcet's Syndrome

Who this might be right for
Behcet Syndrome
NYU Langone Health 1
Post-approval studies (Phase 4)Study completedNCT01734382
What this trial is testing

Decreased Dose Frequency in Participants With Systemic Juvenile Arthritis Who Experience Laboratory Abnormalities During Treatment With RoActemra/Actemra (Tocilizumab)

Who this might be right for
Juvenile Idiopathic Arthritis
Hoffmann-La Roche 35
Testing effectiveness (Phase 2)WithdrawnNCT02997956
What this trial is testing

Study of Tocilizumab in Patients With Hepatocellular Carcinoma (HCC) Undergoing Transarterial Chemoembolization (TACE)

Who this might be right for
Hepatocellular Carcinoma
University of Michigan Rogel Cancer Center
Large-scale testing (Phase 3)Study completedNCT06048224
What this trial is testing

Phase III Clinical Trial Comparing the Safety, Efficacy, and Immunogenicity of Recombinant Anti-interleukin-6 Receptor Humanized Monoclonal Antibody Injection in Combination With Methotrexate and Jamelor ® in the Treatment of Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Moderate to Severe Active Rheumatoid Arthritis
Zhejiang Hisun Pharmaceutical Co. Ltd. 669
Large-scale testing (Phase 3)Study completedNCT04826588
What this trial is testing

Randomised Evaluation of COVID-19 Therapy (RECOVERY) in Children With PIMS-TS in Switzerland (SWISSPED-RECOVERY)

Who this might be right for
Paediatric Inflammatory Multisystem Syndrome-Temporally Associated With SARS-CoV-2 (PIMS-TS)
University Children's Hospital Basel 76
Post-approval studies (Phase 4)Study completedNCT02682823
What this trial is testing

Tocilizumab Real-Life Human Factors (RLHFs) Validation Study

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 91
Post-approval studies (Phase 4)Study completedNCT03737708
What this trial is testing

A Study Comparing Biologics + Methotrexate With Biologics + Tacrolimus in Patients With Rheumatoid Arthritis (RA)

Who this might be right for
Rheumatoid Arthritis (RA)
Astellas Pharma Korea, Inc. 21
Not applicableStudy completedNCT02963402
What this trial is testing

Immunoregulatory Mechanisms of Treg Cells Induced by Tocilizumab

Who this might be right for
Arthritis,Rheumatoid
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 35
Early research (Phase 1)Study completedNCT05164133
What this trial is testing

A Study Evaluating Tocilizumab in Pediatric Patients Hospitalized With COVID-19

Who this might be right for
COVID-19
Hoffmann-La Roche 2
Testing effectiveness (Phase 2)Study completedNCT02108600
What this trial is testing

Tocilizumab for Renal Graft Inflammation

Who this might be right for
Late Complication From Kidney Transplant
Flavio Vincenti 33
Early research (Phase 1)Study completedNCT03923738
What this trial is testing

Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Tocilizumab (TCZ) Administered to Participants With Giant Cell Arteritis (GCA).

Who this might be right for
Giant Cell Arteritis
Hoffmann-La Roche 24
Large-scale testing (Phase 3)Study completedNCT01941095
What this trial is testing

Subcutaneous Tocilizumab as Monotherapy and/or in Combination With Non-Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs) in Participants With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 100
Large-scale testing (Phase 3)Study completedNCT01673919
What this trial is testing

A Long-Term Extension Study of RoActemra/Actemra (Tocilizumab) in Patients With Juvenile Idiopathic Arthritis From France Who Completed WA19977 Core Study

Who this might be right for
Juvenile Idiopathic Arthritis
Hoffmann-La Roche 7
Large-scale testing (Phase 3)Study completedNCT01353859
What this trial is testing

RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Non-biologic DMARDs

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 39
Testing effectiveness (Phase 2)Study completedNCT04363736
What this trial is testing

Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia

Who this might be right for
COVID-19 Pneumonia
Hoffmann-La Roche 97
Not applicableStudy completedNCT02419937
What this trial is testing

Short-Term Application of Tocilizumab Following Myocardial Infarction

Who this might be right for
Myocardial Infarction
Keesler Air Force Base Medical Center 28
Large-scale testing (Phase 3)Study completedNCT01256736
What this trial is testing

To Evaluate 1 Year Extension Study of the Efficacy and Safety of Tocilizumab in Patients With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
JW Pharmaceutical 89
Post-approval studies (Phase 4)UnknownNCT01980836
What this trial is testing

Effect of Tocilizumab to the Cellular Immune Response to Influenza Vaccine

Who this might be right for
Rheumatoid ArthritisCellular Immune Response
Tel-Aviv Sourasky Medical Center 40
Testing effectiveness (Phase 2)Study completedNCT04339712
What this trial is testing

Personalised Immunotherapy for SARS-CoV-2 (COVID-19) Associated With Organ Dysfunction

Who this might be right for
COVID-19Virus DiseasesMacrophage Activation Syndrome+1 more
Hellenic Institute for the Study of Sepsis 102
Not applicableStudy completedNCT03291457
What this trial is testing

Evaluate the Use of Glucocorticoids in Combination With Tocilizumab in Daily Clinical Practice

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 101
Next Page